We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

European Medicines Agency Approves Orphan Medicinal Product Application of DCPrime's AML Vaccine

News   Feb 02, 2012

 
European Medicines Agency Approves Orphan Medicinal Product Application of DCPrime's AML Vaccine
 
 
 

RELATED ARTICLES

The "Secret Weapon" of Virus-Neutralizing Antibodies

News

A new study in mice has explored why certain antibodies are highly effective in protecting the body against debilitating viruses like chikungunya.

READ MORE

Antibody Therapy That Trains Phagocytes to Destroy Tumors Is Tested in Patients

News

An immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumors in several mouse models. The development of the therapy has now progressed to patient testing in a phase I/II clinical trial.

READ MORE

Minimizing Toxicity of Breast Cancer Treatment

News

De-escalation of treatment strategies aims to minimize toxicity while maintaining efficacy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE